ReviewAntibodies (Basel, Switzerland)2025
Breakthrough for Anticancer Immunotherapy: Current Advances in Manufacturing Protocols of Chimeric Antigen Receptor-Based Therapies.
Yuxin Qian et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.